Agios Pharmaceuticals AGIO Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $89.13M+16.9% | $76.25M-13.6% | $88.21M-36.7% | $139.26M-31.4% | ||
| $765.3M-6.4% | $817.46M+18.7% | $688.72M+7.0% | $643.86M-21.2% | ||
| $10.58M+157% | $4.11M+46.2% | $2.81M— | $0-100% | ||
| $32.92M+19.2% | $27.62M+44.8% | $19.08M+125% | $8.49M— | ||
| $942.05M-2.4% | $965.6M+15.8% | $833.84M+0.1% | $832.77M-21.7% | ||
| $10.78M-7.7% | $11.68M-24.1% | $15.38M-33.1% | $22.99M-20.5% | ||
| $1.3B-22.0% | $1.66B+77.5% | $937.12M-24.3% | $1.24B-13.8% | ||
| $18.36M+10.3% | $16.64M+70.2% | $9.78M-47.5% | $18.62M+11.5% | ||
| $82.21M+1.3% | $81.16M+19.4% | $67.96M+8.5% | $62.63M+4.7% | ||
| $104.11M-14.8% | $122.24M-3.1% | $126.1M-8.6% | $137.9M-5.4% | ||
| $75K+2.7% | $73K+1.4% | $72K+1.4% | $71K0.0% | ||
| -$561.71M-277% | -$148.92M+81.9% | -$822.65M-74.8% | -$470.56M-97.1% | ||
| $1.19B-22.6% | $1.54B+90.0% | $811.02M-26.3% | $1.1B-14.8% | ||
| $1.3B-22.0% | $1.66B+77.5% | $937.12M-24.3% | $1.24B-13.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Agios Pharmaceuticals's total assets?
- Agios Pharmaceuticals (AGIO) holds $1.2B in total assets, down 23.8% year over year.
- How much debt does Agios Pharmaceuticals have?
- Agios Pharmaceuticals carries $35.7M in total debt against $1.1B of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Agios Pharmaceuticals have?
- Agios Pharmaceuticals holds $113.6M in cash and equivalents.
- Can Agios Pharmaceuticals cover its short-term obligations?
- Its current ratio is 14.19 — current assets exceed current liabilities.
- Where does Agios Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Agios Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
